Status:
COMPLETED
Clinical Application of Autologous Three-Cellular Cultured Skin Substitutes (CSS)
Lead Sponsor:
University of Roma La Sapienza
Conditions:
Burns
Ulcers
Eligibility:
All Genders
1-70 years
Phase:
NA
Brief Summary
The aim of this work was to present the investigators experience in the use of autologous three-cellular cultured skin substitutes (CSS) consisting of cultured keratinocytes, melanocytes and fibroblas...
Detailed Description
Background and Objective: Permanent wound closure remains a limiting factor in the closure of extensive, full-thickness loss of substance. The aim of this work was to present our experience in the us...
Eligibility Criteria
Inclusion
- of extensive full-thickness loss of substance
Exclusion
- location: face
- all contra indications for surgery
- coagulation disorders
- infection
- allergic reactions
- collagenopathies
- malignant cancer and chemotherapy
- immunodeficiencies
- diabetes
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00718978
Start Date
June 1 2003
End Date
July 1 2007
Last Update
September 9 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dipartimento Malattie Cutanee-Veneree e Chirurgia Plastica e Ricostruttiva universita' "La Sapienza" Roma
Roma, Italy, 00161